financetom
Business
financetom
/
Business
/
Ridgeline Minerals and Nevada Gold Mines Begin 6,000-meter Drill Program at Swift Gold Project, Nevada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ridgeline Minerals and Nevada Gold Mines Begin 6,000-meter Drill Program at Swift Gold Project, Nevada
Jul 30, 2025 12:11 PM

02:51 PM EDT, 07/30/2025 (MT Newswires) -- Ridgeline Minerals ( RDGMF ) was edging lower Wednesday afternoon as it announced the commencement of a 6,000-meter program at its Swift gold project, currently being operated under an exploration earn-in agreement with Nevada Gold Mines.

The company, in noting that Nevada Gold Mines approved a 2025 exploration budget of up to US$5 million, said the drill program will "build off the success" of the 2024 framework drilling campaign where both holes delivered "significant" gold intercepts in the SW Swift target area including 1.1 meters grading 10.4 grams per tonne (g/t) gold (Au) within 2.7m grading 7.0 g/t Au in SW24-006 and 24.7m grading 0.5 g/t Au in SW24-007.

At the SW Swift Target, the company said that four of the five holes are planned to test along strike of previous high-grade gold intercepts at the "projected intersection of cross cutting fault zones where they intersect a modeled fold hinge," on the hanging wall side of the Mill Creek thrust.

Ridgeline Minerals ( RDGMF ) said that the fifth hole at the Mill Creek Target will step several kilometers to the north of SW Swift and test favourable Wenban formation limestones along the hanging wall side of the Mill Creek thrust.

"Swift continues to be a core asset in our exploration portfolio and represents just under 50% of our $11M exploration budget in 2025," said Ridgeline Minerals' ( RDGMF ) President, Chief Executive Officer and Director, Chad Peters. "The Nevada Gold Mines teams' systematic approach to deep exploration at Swift yielded the first ever high-grade gold intercept in our 2024 program, and we are very excited to see the results of this aggressive drill campaign in 2025."

The company's shares were last seen down $0.01 at $0.18 on the TSX Venture Exchange.

Price: 0.18, Change: -0.01, Percent Change: -5.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Boeing Reportedly Close to Buying Back Spirit AeroSystems
Update: Market Chatter: Boeing Reportedly Close to Buying Back Spirit AeroSystems
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- (Adds deal details in fourth and sixth paragraph) Boeing ( BA ) is close to buying back its former subsidiary Spirit AeroSystems ( SPR ) following the struggling supplier's notable progress in separate talks with European rival Airbus, Reuters reported Thursday, citing people familiar with the matter. The company started discussions earlier this...
Sector Update: Consumer
Sector Update: Consumer
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- Consumer stocks were edging higher pre-bell Friday with the Consumer Staples Select Sector SPDR Fund (XLP) marginally advancing and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.2% recently. PVH (PVH) shares were up over 2% after the company's Tommy Hilfiger brand said it has entered a multi-year partnership with the US...
Therma Bright Completes Second, Final Tranche of Fully Subscribed Non-Brokered Private Placement
Therma Bright Completes Second, Final Tranche of Fully Subscribed Non-Brokered Private Placement
Jun 21, 2024
08:46 AM EDT, 06/21/2024 (MT Newswires) -- Therma Bright ( TBRIF ) , a developer and investment partner in various diagnostic and medical device technologies, said on Friday that it has completed the second and final tranche of its non-brokered private placement. In the final tranche, Therma issued about 14.6 million units at $0.01 apiece for $145,500. Together with the...
Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy
Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) said Friday that it has resubmitted its New Drug Application for sotagliflozin to supplement insulin therapy for persons with type 1 diabetes and chronic kidney disease, following multiple consultations with the US Food and Drug Administration. The application remains in filed status at the FDA and the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved